National Cancer Center

 

Site:
National Cancer Center
Address:
 
City:
Singapore
State:
Zip:
Country:
Singapore

 

8 trials at this site

 

 

3
Recruiting
Active
QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib
NCT03673501
2
Recruiting
Active
Imatinib + Regorafenib
NCT02365441
2
Recruiting
Active
LOXO-101
NCT02576431
3
Ongoing, but not recruiting
Closed
Regorafenib (BAY 73-4506)
NCT01271712
1
Ongoing, but not recruiting
Closed
BKM120 + MEK162
NCT01363232
3
Completed
Closed
Nilotinib or Imatinib
NCT00785785
3
Active, not recruiting
Closed
QINLOCK Ripretinib DCC-2618
NCT03353753
3
Active, not recruiting
Active
Avapritinib or Regorafenib
NCT03465722